Michael Gennaco Email

Manager Quality Control EM and Material Control . Akston Biosciences Corporation

Current Roles

Employees:
73
Revenue:
$11.3M
About
Akston Biosciences Corporation is a leader in the field of insulin engineering.  The company was founded in 2011 by the former SmartCells, Inc. team who developed the world’s first clinical glucose-responsive insulin (acquired by Merck & Co. in 2010).  Combining its core expertise with modern biotechnology manufacturing techniques, Akston is developing new classes of biologic therapeutics for use in autoimmune Type 1 diabetes prevention, ultra-long acting insulin therapy, and oncology to dramatically improve both human and animal health.  The company has raised over $18 million in equity financing from the management team and private investors, as well as $10 million from the NIH and the Helmsley Charitable Trust.
Akston Biosciences Corporation Address
100 Cummings Center
Beverly, MA
United States
Akston Biosciences Corporation Email

Past Companies

Akston Biosciences CorporationManager Quality Control EM and Material Control
Akston Biosciences CorporationQuality Control Scientist
DPS Group GlobalValidation Engineer

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.